- About
- PsychU For You
- Topics
- Events
- Content
Impact of Adherence on Patients with BP I Disorder
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Impact of Adherence on Patients with BP I Disorder
Treatment non-adherence is a dilemma in bipolar disorder and is one of the leading challenges in providing effective treatments for people diagnosed with BP I disorder. During our discussion today, Dr. Sajatovic and Dr. Goldberg will discuss and define some of these challenges and provide the latest information on treatment-related determinants of adherence. They will also discuss some of the factors important to adherence.
Martha Sajatovic, MD
Psychiatrist, Director Neurological and Behavioral Outcomes Center, University Hospital Cleveland Medical Center and Professor, Case Western Reserve University School of Medicine
MoreMartha Sajatovic, MD holds the Willard Brown Chair in Neurological Outcomes at University Hospitals Cleveland Medical Center (UH CMC) and the Rocco L. Motto Professorship in Child & Adolescent Psychiatry. Dr. Sajatovic directs the Neurological and Behavioral Outcomes Center at UHCMC/Case Western Reserve University. She has subspecialty certification in Behavioral Neurology & Neuropsychiatry. Dr. Sajatovic is a Professor of Psychiatry and Neurology at Case Western Reserve University School of Medicine (CWRU) in Cleveland, Ohio. Dr. Sajatovic is a researcher, educator, and clinician who has devoted herself to studying and treating traditionally, hard-to-treat populations with central nervous system disorders. Dr. Sajatovic’s research interests have focused on neuropsychiatric outcomes of brain disorders across the life-span, including epilepsy, stroke, Alzheimer’s disease, and other types of dementia and Parkinson’s disease. She has authored or co-authored over 250 peer-reviewed publications and has published over 40 book chapters or books on neuropsychiatric topics. Dr. Sajatovic has been a recipient of the Exemplary Psychiatrist Award bestowed by the National Alliance for the Mentally Ill (NAMI), was a Depression and Bipolar Support Alliance (DBSA) Gerald Klerman Investigator Award winner in 2006 and 2016, and in 2018 received the Rebecca Goldberg Kaufman American Epilepsy Society (AES) Clinical Award in Ethical Neuropsychiatry.
Joseph Goldberg, MD
Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai
MoreDr. Goldberg currently serves as the Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and serves on the Board of Directors for the American Society of Clinical Psychopharmacology. Dr. Goldberg has published over 200 peer-reviewed papers on topics related to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology.
Elizabeth DiNapoli, PhD (OPDC)
Senior Medical Science Liaison
MoreDr. DiNapoli earned her PhD from the University of Alabama.Speakers Martha Sajatovic, MD and Joseph Goldberg, MD are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Speakers Elizabeth DiNapoli, PhD, is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.Related Events
Registration
- PsychU For You
